Story thread · 4 reports / 4 sources
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
statnews.com · 2h
How the coverage leans
Across 4 sources · syndicated copies counted once
The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs
First report: Big Pharma Needs New Drugs. China Has Them — bloomberg.com, 2d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.